156 related articles for article (PubMed ID: 28517007)
1. Generation of a cell-permeable cycloheptapeptidyl inhibitor against the peptidyl-prolyl isomerase Pin1.
Bedewy W; Liao H; Abou-Taleb NA; Hammad SF; Nasr T; Pei D
Org Biomol Chem; 2017 May; 15(21):4540-4543. PubMed ID: 28517007
[TBL] [Abstract][Full Text] [Related]
2. A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1.
Jiang B; Pei D
J Med Chem; 2015 Aug; 58(15):6306-12. PubMed ID: 26196061
[TBL] [Abstract][Full Text] [Related]
3. Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1.
Liu T; Liu Y; Kao HY; Pei D
J Med Chem; 2010 Mar; 53(6):2494-501. PubMed ID: 20180533
[TBL] [Abstract][Full Text] [Related]
4. Cell-permeable bicyclic peptide inhibitors against intracellular proteins.
Lian W; Jiang B; Qian Z; Pei D
J Am Chem Soc; 2014 Jul; 136(28):9830-3. PubMed ID: 24972263
[TBL] [Abstract][Full Text] [Related]
5. An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.
Ieda N; Itoh K; Inoue Y; Izumiya Y; Kawaguchi M; Miyata N; Nakagawa H
Bioorg Med Chem Lett; 2019 Feb; 29(3):353-356. PubMed ID: 30585173
[TBL] [Abstract][Full Text] [Related]
6. Computational and Structure-Based Development of High Potent Cell-Active Covalent Inhibitor Targeting the Peptidyl-Prolyl Isomerase NIMA-Interacting-1 (Pin1).
Liu L; Zhu R; Li J; Pei Y; Wang S; Xu P; Wang M; Wen Y; Zhang H; Du D; Ding H; Jiang H; Chen K; Zhou B; Yu L; Luo C
J Med Chem; 2022 Feb; 65(3):2174-2190. PubMed ID: 35089030
[TBL] [Abstract][Full Text] [Related]
7. The role of Pin1 in the development and treatment of cancer.
Min SH; Zhou XZ; Lu KP
Arch Pharm Res; 2016 Dec; 39(12):1609-1620. PubMed ID: 27572155
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Pin1 inhibitory activity of thiazole derivatives.
Zhao H; Cui G; Jin J; Chen X; Xu B
Bioorg Med Chem; 2016 Nov; 24(22):5911-5920. PubMed ID: 27692510
[TBL] [Abstract][Full Text] [Related]
9. Identification of a potent and selective covalent Pin1 inhibitor.
Pinch BJ; Doctor ZM; Nabet B; Browne CM; Seo HS; Mohardt ML; Kozono S; Lian X; Manz TD; Chun Y; Kibe S; Zaidman D; Daitchman D; Yeoh ZC; Vangos NE; Geffken EA; Tan L; Ficarro SB; London N; Marto JA; Buratowski S; Dhe-Paganon S; Zhou XZ; Lu KP; Gray NS
Nat Chem Biol; 2020 Sep; 16(9):979-987. PubMed ID: 32483379
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel thiazole-based derivatives as human Pin1 inhibitors.
Du L; Wang X; Cui G; Xu B
Bioorg Med Chem; 2021 Jan; 29():115878. PubMed ID: 33246256
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 4,6-bis(benzyloxy)-3-phenylbenzofuran as a novel Pin1 inhibitor to suppress hepatocellular carcinoma via upregulating microRNA biogenesis.
Fan X; He H; Li J; Luo G; Zheng Y; Zhou JK; He J; Pu W; Zhao Y
Bioorg Med Chem; 2019 Jun; 27(11):2235-2244. PubMed ID: 31027708
[TBL] [Abstract][Full Text] [Related]
12. Targeting Peptidyl-prolyl Cis-trans Isomerase NIMA-interacting 1: A Structure-based Virtual Screening Approach to Find Novel Inhibitors.
da Costa KS; Galúcio JM; de Jesus DA; Gomes GC; Lima E Lima AH; Taube PS; Dos Santos AM; Lameira J
Curr Comput Aided Drug Des; 2020; 16(5):605-617. PubMed ID: 31654518
[TBL] [Abstract][Full Text] [Related]
13. Discovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1.
Duncan KE; Dempsey BR; Killip LE; Adams J; Bailey ML; Lajoie GA; Litchfield DW; Brandl CJ; Shaw GS; Shilton BH
J Med Chem; 2011 Jun; 54(11):3854-65. PubMed ID: 21545152
[TBL] [Abstract][Full Text] [Related]
14. Food polyphenols targeting peptidyl prolyl cis/trans isomerase Pin1.
Hidaka M; Kosaka K; Tsushima S; Uchida C; Takahashi K; Takahashi N; Tsubuki M; Hara Y; Uchida T
Biochem Biophys Res Commun; 2018 May; 499(3):681-687. PubMed ID: 29608894
[TBL] [Abstract][Full Text] [Related]
15. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
[TBL] [Abstract][Full Text] [Related]
16. Structure-Based Design of Novel Benzimidazole Derivatives as Pin1 Inhibitors.
Wang S; Guan L; Zang J; Xing K; Zhang J; Liu D; Zhao L
Molecules; 2019 Mar; 24(7):. PubMed ID: 30934730
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel selenium derivatives as Pin1 inhibitors by high-throughput screening.
Subedi A; Shimizu T; Ryo A; Sanada E; Watanabe N; Osada H
Biochem Biophys Res Commun; 2016 Jun; 474(3):528-533. PubMed ID: 27120460
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of pyrimidine derivatives as novel human Pin1 inhibitors.
Cui G; Jin J; Chen H; Cao R; Chen X; Xu B
Bioorg Med Chem; 2018 May; 26(8):2186-2197. PubMed ID: 29576270
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of novel human Pin1 inhibitors (III): optimizing affinity beyond the phosphate recognition pocket.
Guo C; Hou X; Dong L; Marakovits J; Greasley S; Dagostino E; Ferre R; Johnson MC; Humphries PS; Li H; Paderes GD; Piraino J; Kraynov E; Murray BW
Bioorg Med Chem Lett; 2014 Sep; 24(17):4187-91. PubMed ID: 25091930
[TBL] [Abstract][Full Text] [Related]
20. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries.
Wildemann D; Erdmann F; Alvarez BH; Stoller G; Zhou XZ; Fanghänel J; Schutkowski M; Lu KP; Fischer G
J Med Chem; 2006 Apr; 49(7):2147-50. PubMed ID: 16570909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]